DURHAM, N.C., March 02, 2026 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced that the Company’s management team will be participating in the following investor conferences during the month of March. TD Cowen 46th Annual Healthcare ConferencePresentation: Wednesday March 4, 2026, 10:30-11:00 am Eastern TimeWebcast Link: Click Here Barclays 28th Annual Globa ...